BlackRock’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

BlackRock’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,564,333	Closed	-$160M	–	6088
2022 Q1	$160M	Sell	8,564,333 -167,745	-2%	-$3.02M	﹤0.01%	1821
2021 Q4	$187M	Buy	8,732,078 +1,645,339	+23%	+$32.4M	﹤0.01%	1784
2021 Q3	$131M	Buy	7,086,739 +953,422	+16%	+$19.2M	﹤0.01%	2034
2021 Q2	$131M	Sell	6,133,317 -437,491	-7%	-$8.9M	﹤0.01%	2086
2021 Q1	$127M	Buy	+6,570,808	New	+$116M	﹤0.01%	2044

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

BlackRock's OCDX Position: Q2 2022 in Review

BlackRock sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 8,564,333 shares — an estimated $160M sold.

BlackRock first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $187M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

BlackRock reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
BlackRock sold 8,564,333 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $160M.
BlackRock first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
BlackRock's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $187M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.